Compound

Details Compound Compound

2006-10-31

2006-10-31

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S312000, C549S281000, C549S403000

Reexamination Certificate

active

07129269

ABSTRACT:
The instant invention relates to sulphamate compounds of formula I, wherein A represents a ring structure, B represents a ring structure, D a ring structure, C is a bond, E is a link joining ring structure B to the ring structure D, X represents a suitable first group, and Y represents a suitable second group; wherein one ring of the compound is a phenolic ring; and wherein any one of ring structures A, B and D has bound thereto a sulphamate group.

REFERENCES:
patent: 4032545 (1977-06-01), Borror
patent: 4600788 (1986-07-01), Creuzet et al.
patent: 4618622 (1986-10-01), Schlecker
patent: 4829084 (1989-05-01), Bailey
patent: 4891298 (1990-01-01), Waller
patent: 4900727 (1990-02-01), Kattige et al.
patent: 6011024 (2000-01-01), Reed
patent: 6187766 (2001-02-01), Reed
patent: 6288107 (2001-09-01), Li
patent: 6506792 (2003-01-01), Reed et al.
patent: 0 125 195 (1984-11-01), None
patent: 0 241 003 (1987-10-01), None
patent: 0403184 (1990-08-01), None
patent: WO 92/21353 (1992-12-01), None
patent: WO 93/05064 (1993-03-01), None
patent: WO 93/05064 (1993-04-01), None
patent: WO 97/30041 (1997-08-01), None
L. W. Lawrence Woo, et al., Heteroatom-Substituted Analogues Of The Active-Site Directed Inhibitor Estra-1,3,5(10)-Trien-17-One-3-Sulphamate Inhibit Estrone Sulphatase By A Different Mechanism, J. Steroid Biochem. Molec. Biol. 1996, vol. 57, No. 1/2 p. 79-88.
M. J. Reed et al., The Role Of Cytokines And Sulphatase Inhibitors In Regulating Oestrogen Synthesis In Breast Tumors, J. Steriod Biochem. Molec. Biol., 1995, vol. 53, No. 1-6, p. 413-420.
Atul Purohit, et al., In Vivo Activity of 4-Methylcoumarin-7-O-Sulfamate, A Nonsteroidal, Nonestrogenic Steroid Sulfatase Inhibitor, Cancer Research 56, 1996, p. 4950-4955.
L. W. Lawrence Woo, Active Site Directed Inhibition Of Estrone Sulfatase By Nonsteroidal Coumarin Sulfamates, J. Med. Chem., 1996, 39, p. 1349-1351.
Butenas, et al.; 28606J: 6-Peptidylamino-1-naphthalenesulfonamides Useful as Fluorogenic Proteolytic Enzymes Substrates, Chemical Abstracts 1995; 123(3):28606.
Howarth, et al.; “Estrone Sulfamates: Potent Inhibitors of Estrone Sulfatase with Therapeutics Potential”, Journal of Medicinal Chemistry 1994; 37(2):219-221.
Kurano et al.; “290713m: Preparation of Flavone Derivative as Virucides”; Chemical Abstracts 1995; 122(23):1022.
Leonardi, et al.; “225315b: Bicyclic Heterocyclic Derivatives having α, -adrenergic and 5HT1aSerotonergic Activities”, Chemical Abstracts 1997; 126(17):2525316.
Nakai, et al.; “71581U: Preparation of Naphthyloxazolidone Derivatives as Selective Monoamine Oxidase A Inhibitors”, Chemical Abstracts 1991, 115(7):796.
Nelson, et al.; “Murine Arylsulfatase C: Evidence for two Isozymes”, Experienta 1982; 39:740-742.
Purohit, et al.; “Inactivation of Steroid Sulfatase by an Active Site-Directed Inhibitor, Estrone-3-O-Sulfamate”, Biochemistry 1995, 34(36):11508-11514.
Purohit, et al.; “In Vivo Activity of 4-Methylcoumarin-7-O-Sulfamate, A Nonsteroidal, Nonestrogenic Steroid Sulfatase Inhibitor”, Cancer Research 1996, 56(21):4950-4955.
Sahm, et al.; “Development of an Oral Formulation for Oestrone 3-O-Sulphate, a Potent Sulphatase Inhibitor”, Pharmaceutical Sciences 1996; 2:17-20.

Affiliated with

Also associated with

Rating

Compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3718740